Fmr LLC Novavax Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Novavax Inc stock. As of the latest transaction made, Fmr LLC holds 24,683 shares of NVAX stock, worth $309,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,683

Previous 8,060 206.24%

Holding current value

$309,031

Previous $38,000 721.05%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $64,663 - $348,584	16,623 Added 206.24%	24,683 $312,000
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $19,318 - $30,930	5,138 Added 175.84%	8,060 $38,000
Q4 2023 Feb 13, 2024	SELL	$4.8 - $7.67 $37,094 - $59,273	-7,728 Reduced 72.56%	2,922 $14,000
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $6,197 - $8,863	-910 Reduced 7.87%	10,650 $77,000
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $53,453 - $76,293	8,014 Added 226.0%	11,560 $85,000
Q1 2023 May 11, 2023	SELL	$5.76 - $12.48 $7,585 - $16,436	-1,317 Reduced 27.08%	3,546 $24,000
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $11,500 - $32,501	1,298 Added 36.41%	4,863 $49,000
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $9,209 - $38,516	506 Added 16.54%	3,565 $65,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $2.19 Million - $4.55 Million	-60,410 Reduced 95.18%	3,059 $157,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $9.4 Million - $19.3 Million	-134,776 Reduced 67.98%	63,469 $4.67 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $170 Million - $275 Million	-1,263,664 Reduced 86.44%	198,245 $28.4 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $609 Million - $926 Million	-3,423,294 Reduced 70.07%	1,461,909 $303 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $591 Million - $1.26 Billion	4,885,203 New	4,885,203 $1.04 Billion

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $979M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account